Mr. Jack Kay at the Industry, Science and Technology Committee

On April 23rd, 2007. See this statement in context.

April 23rd, 2007 / 4:35 p.m.

President and Chief Executive Officer, Apotex Inc.; Canadian Generic Pharmaceutical Association

The product you have here that we spent $2 million developing is sold in Canada by the patent holders--when you combine the different components--at around $4.50 per tablet. We have offered this to MSF at our cost, which is 39¢. So I'm not sure what list you have in front of you.

See context to find out what was said next.